Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy.

about

The role of renin-angiotensin system in the chronic allograft nephropathy: an immunohistochemical study.

P2860

Q53579926-35D3E23D-A600-4A43-A784-6431CC4A316A

P2860

Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy.

Item

http://www.wikidata.org/entity/Q46045283

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Synergistic effect of mycophen ...... chronic allograft nephropathy.

@en

Synergistic effect of mycophen ...... chronic allograft nephropathy.

@nl

type

Item

label

Synergistic effect of mycophen ...... chronic allograft nephropathy.

@en

Synergistic effect of mycophen ...... chronic allograft nephropathy.

@nl

prefLabel

Synergistic effect of mycophen ...... chronic allograft nephropathy.

@en

Synergistic effect of mycophen ...... chronic allograft nephropathy.

@nl

P1476

Synergistic effect of mycophen ...... chronic allograft nephropathy.

@en

P2093

A Pacheco-Silva

http://www.w3.org/2001/XMLSchema#string

G Mastroianni-Kirsztajn

http://www.w3.org/2001/XMLSchema#string

G T Moscoso-Solorzano

http://www.w3.org/2001/XMLSchema#string

K S Ozaki

http://www.w3.org/2001/XMLSchema#string

M F Franco

http://www.w3.org/2001/XMLSchema#string

N O S Câmara

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Chronic renal allograft rejection: pathophysiologic considerations.

Routine renin-angiotensin system blockade in renal transplantation?

The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation.

No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report.

Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil.

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.

Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure.

Effect of angiotensin II antagonism on the regression of kidney disease in the rat.

P304

445-452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0100-879X2009000500008

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

216688589

http://www.w3.org/2001/XMLSchema#string

P698

19377794

http://www.w3.org/2001/XMLSchema#string

Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy.

about

P2860

P2860

Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698